NeuroPace, Inc. (NPCE)
13.99
-0.04
(-0.29%)
USD |
NASDAQ |
Aug 24, 16:00
13.99
0.00 (0.00%)
After-Hours: 20:00
NeuroPace Enterprise Value : 497.85M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 497.85M |
| August 21, 2026 | 499.22M |
| August 20, 2026 | 498.87M |
| August 19, 2026 | 520.13M |
| August 18, 2026 | 514.30M |
| August 17, 2026 | 507.79M |
| August 14, 2026 | 524.59M |
| August 13, 2026 | 515.67M |
| August 12, 2026 | 517.39M |
| August 11, 2026 | 534.19M |
| August 10, 2026 | 528.36M |
| August 07, 2026 | 526.64M |
| August 06, 2026 | 494.76M |
| August 05, 2026 | 487.90M |
| August 04, 2026 | 502.99M |
| August 03, 2026 | 481.05M |
| July 31, 2026 | 460.13M |
| July 30, 2026 | 489.62M |
| July 29, 2026 | 485.85M |
| July 28, 2026 | 543.10M |
| July 27, 2026 | 542.76M |
| July 24, 2026 | 525.96M |
| July 23, 2026 | 521.50M |
| July 22, 2026 | 518.07M |
| July 21, 2026 | 548.24M |
| Date | Value |
|---|---|
| July 20, 2026 | 558.18M |
| July 17, 2026 | 569.50M |
| July 16, 2026 | 582.87M |
| July 15, 2026 | 573.95M |
| July 14, 2026 | 561.27M |
| July 13, 2026 | 605.15M |
| July 10, 2026 | 604.81M |
| July 09, 2026 | 600.01M |
| July 08, 2026 | 593.49M |
| July 07, 2026 | 628.46M |
| July 06, 2026 | 612.35M |
| July 02, 2026 | 571.55M |
| July 01, 2026 | 558.87M |
| June 30, 2026 | 562.98M |
| June 29, 2026 | 577.00M |
| June 26, 2026 | 574.97M |
| June 25, 2026 | 571.24M |
| June 24, 2026 | 566.49M |
| June 23, 2026 | 556.32M |
| June 22, 2026 | 537.67M |
| June 18, 2026 | 546.48M |
| June 17, 2026 | 530.55M |
| June 16, 2026 | 525.80M |
| June 15, 2026 | 537.67M |
| June 12, 2026 | 546.82M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tandem Diabetes Care, Inc. | 1.828B |
| CVRx, Inc. | 78.72M |
| Accuray, Inc. | 174.94M |
| Orthofix Medical, Inc. | 556.24M |
| ResMed, Inc. | 32.88B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.20M |
| Revenue (Quarterly) | 22.83M |
| Total Expenses (Quarterly) | 29.03M |
| EPS Diluted (Quarterly) | -0.1818 |
| Gross Profit Margin (Quarterly) | 82.83% |
| Profit Margin (Quarterly) | -27.16% |
| Earnings Yield | -4.06% |
| Normalized Earnings Yield | -4.038 |